Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome

Clinical Chemistry

Volumn 52, Issue 3, 2006, Pages 421-429

  Pang, Ronald T K ^a   Poon, Terence C W ^a   Chan, K C Allen ^a   Lee, Nelson L S ^a   Chiu, Rossa W K ^a   Tong, Yu Kwan ^a   Wong, Ronald M Y ^a   Chim, Stephen S C ^a   Ngai, Sai M ^a   Sung, Joseph J Y ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3C; FIBRINOGEN; IMMUNOGLOBULIN KAPPA CHAIN; PROTEOME; VIRUS RNA;

ADULT; AGED; ARTICLE; BIOINFORMATICS; BIOSTATISTICS; CLINICAL ARTICLE; COMMUNICABLE DISEASE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PROTEOMIC FINGERPRINTING; PROTEOMICS; ROC CURVE; SARS CORONAVIRUS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEOME; ROC CURVE; SARS VIRUS; SERUM; SEVERE ACUTE RESPIRATORY SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 33644525295     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.061689     Document Type: Article

References (41)

1. World Health Organization. WHO issues consensus document on the epidemiology of SARS. Wkly Epidemiol Rec 2003;78:373-5.
2. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, et al. The genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
3. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
4. Tsui SK, Chim SS, Lo YM, Chinese University of Hong Kong Molecular SRG. Coronavirus genomic-sequence variations and the epidemiology of the severe acute respiratory syndrome. N Engl J Med 2003;349:187-8.
5. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
6. G. Ng EK, Hui DS, Chan KC, Hung EC, Chiu RW, Lee N, et al. Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 2003;49:1976-80.
7. Yip TT, Chan JW, Cho WC, Wang Z, Kwan TL, Law SC, et al. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 2005;51:47-55.
8. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-60.
9. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004;292:462-9.
10. Poon TC, Chan KC, Ng PC, Chiu RW, Ang IL, Tong YK, et al. Serial analysis of plasma proteomic signatures in pediatric patients with severe acute respiratory syndrome and correlation with viral load. Clin Chem 2004;50:1452-5.
11. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, et al. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 2005;51:56-64.
12. Mazzulli T, Low DE, Poutanen SM. Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clin Chem 2005;51:6-7.
13. Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, et al. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem 2005;51:328-35.
14. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
15. Pang RT, Poon TC, Wong N, Lai PB, Wong NL, Chan CM, et al. Comparison of protein expression patterns between hepatocellular carcinoma cell lines and a hepatoblastoma cell line. Clin Proteomics 2004;1:313-32.
16. Diamandis EP. Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 2003;49:1272-5.
17. Liao WJ, Li YM, Chen T, He WQ, Lin YP, Li N. Determination of serum acute phase reaction protein in patients with severe acute respiratory syndrome. Zhonghua Yu Fang Yi Xue Za Zhi 2004;38:92-3.
18. Shieh WJ, Hsiao CH, Paddock CD, Guarner J, Goldsmith CS, Tatti K, et al. Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. Hum Pathol 2005;36:303-9.
19. Tse GM, To KF, Chan PK, Lo AW, Ng KC, Wu A, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol 2004;57:260-5.
20. Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol 2003;34:743-8.
21. Guan YJ, Tang XP, Yin CB, Yi ZQ. Study on the damage of liver in patients with SARS. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004;16:267-70.
22. Chan HL, Kwan AC, To KF, Lai ST, Chan PK, Leung WK, et al. Clinical significance of hepatic derangement in severe acute respiratory syndrome. World J Gastroenterol 2005;11:2148-53.
23. Yang Z, Xu M, Yi JQ, Jia WD. Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. Hepatobitiary Pancreat Dis Int 2005;4:60-3.
24. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004;136:95-103.
25. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC, et al. An interferon-γ-related cytokine storm in SARS patients. J Med Virol 2005;75:185-94.
26. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348:1986-94.
27. Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM, et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis 2004;10:1550-7.
28. Chu CM, Poon LL, Cheng VC, Chan KS, Hung IF, Wong MM, et al. Initial viral load and the outcomes of SARS. CMAJ 2004;171:1349-52.
29. Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol 2005;18:1-10.
30. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, et al. CD11c/CD1S on neutrophils recognizes a domain at the N terminus of the Aα chain of fibrinogen. Proc Natl Acad Sci U S A 1991;88:1044-8.
31. Wintroub BU, Coblyn JS, Kaempfer CE, Austen KF. Cleavage of fibrinogen by the human neutrophil neutral peptide-generating protease. Proc Natl Acad Sci U S A 1980;77:5448-52.
32. Davis AE 3rd, Harrison RA. Structural characterization of factor mediated cleavage of the third component of complement. Biochemistry 1982;21:5745-9.
33. Becherer JD, Lambris JD. Identification of the C3b receptor-binding domain in third component of complement. J Biol Chem 1988;263:14586-91.
34. Ehlenberger AG, Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J Exp Med 1977;145:357-71.
35. Weiss L, Delfraissy JF, Vazquez A, Wallon C, Galanaud P, Kazatchkine MD. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation. J Immunol 1987;138:2988-93.
36. Daha MR, Bloem AC, Ballieux RE. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. J Immunol 1984;132:1197-201.
37. Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005;191:1697-704.
38. Lee N, Chan PK, Ip M, Wong E, Ho J, Ho C, et al. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. J Clin Virol 2006;35:179-84.
39. Choi KW, Chau TN, Tsang O, Tso E, Chiu MC, Tong WL, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003;139:715-23.
40. Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003;9:1064-9.
41. Chen CY, Lee CH, Liu CY, Wang JH, Wang LM, Perng RP. Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome. J Chin Med Assoc 2005;68:4-10.